The anxious-depressive attack severity scale: development and initial validation and reliability

BioPsychoSocial Medicine - Tập 15 - Trang 1-6 - 2021
Shota Noda1,2, Satomi Matsumoto3, Naoko Kawasaki3, Mina Masaki4, Itaru Fukui5,6, Hisanobu Kaiya1
1Panic Disorder Research Center, Warakukai Medical Corporation, Tokyo, Japan
2Tokyo Mindfulness Center, Tokyo, Japan
3Akasaka Clinic, Warakukai Medical Corporation, Tokyo, Japan
4Nagoya Mental Clinic, Warakukai Medical Corporation, Nagoya, Japan
5CBT Center, Warakukai Medical Corporation, Tokyo, Japan
6Faculty of Humanities, Tokyo Kasei University, Tokyo, Japan

Tóm tắt

Anxious-depressive attack (ADA) is a symptom complex that comprises sudden intense feelings of anxiety or depression, intrusive rumination of regretful memories or future worries, emotional distress due to painful thoughts, and coping behaviors to manage emotional distress. ADA has been observed trans-diagnostically across various psychiatric disorders. Although the importance of ADA treatment has been indicated, a scale to measure the severity of ADA has not been developed. This study aimed to develop an Anxious-Depressive Attack Severity Scale (ADAS) to measure the severity of ADA symptoms and examine its reliability and validity. A total of 242 outpatients responded to a questionnaire and participated in an interview, which were designed to measure the severity of ADA, depressive, anxiety, anxious depression, and social anxiety symptoms. Based on the diagnostic criteria for ADA, 54 patients were confirmed to have ADA and were included in the main study analyses. The exploratory factor analysis of the ADAS identified a two factor structure: severity of ADA symptoms and ADA frequency and coping behaviors. McDonald’s ωt coefficients were high for the overall scale and the first factor (ωt = .78 and ωt = .83, respectively) but low for the second factor (ωt = .49). The ADAS score was significantly positively correlated with clinical symptoms related to anxiety and depression. The present study demonstrated that the ADAS has sufficient reliability and validity; however, internal consistency was insufficient for the second factor. Overall, the ADAS has potential to be a valuable tool for use in clinical trials of ADA.

Tài liệu tham khảo

Kaiya H. Distinctive clinical features of “anxious-depressive attack”. Anxiety Disord Res. 2017;9(1):2–16. https://doi.org/10.14389/jsad.9.1_2. Kaiya H, Noda S, Takai E, Fukui I, Masaki M, Matsumoto S, et al. Effects of rejection sensitivity on the development of anxious-depressive attack in patients with social anxiety disorder. Anxiety Disord Res. 2020;12(1):37–44. https://doi.org/10.14389/jsad.12.1_37. Kaiya H. Anxious-depressive attack—an overlooked condition—a case report. Anxiety Disord Res. 2016;8(1):22–30. https://doi.org/10.14389/jsad.8.1_22. Matsumoto S, Mina M, Komatsu C, Noguchi K, Kawasaki N, Kishino Y, et al. Examination of the prevalence of anxious-depressive attacks in new outpatients. Hyogo: Abstract of the 12th Japanese Society of Anxiety and Related Disorders Academic Conference; 2020. (In Japanese) Otsubo T, Miyaoka H, Kamijima K. MINI: brief diagnostic structured interview for mental disease. Tokyo: Seiwa Shoten Publishers; 2000. (In Japanese) Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E. The MINI-international neuropsychiatric interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22–33. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62. https://doi.org/10.1136/jnnp.23.1.56. Nakane Y, Williams JBW. Japanese version of structured interview guide for the Hamilton depression rating scale (SIGH-D). Tokyo: Seiwa Shoten Publishers; 2014. (In Japanese) Otsubo T, Koda R, Takashio O, Tanaka K, Eto R, Owashi T, et al. Reliability and validity of the Japanese version of Hamilton anxiety rating scale-interview guide. Jpn J Clin Psychopharmacol. 2005;8:1579–93 (In Japanese). Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–5. https://doi.org/10.1111/j.2044-8341.1959.tb00467.x. Fujisawa D, Nakagawa A, Tajima M, Sado M, Kikuchi T, Iba M, et al. Cross-cultural adaptation of the quick inventory of depressive symptomatology-self report (QIDS-SR-J). Jpn J Stress Sci. 2010;25:43–52 (In Japanese). Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573–83. https://doi.org/10.1016/S0006-3223(02)01866-8. Suyama H, Yokoyama C, Komatsu C, Noguchi K, Kaneko Y, Suzuki S, et al. Development and validation of an anxious depression scale (ADS). Jpn J Behav Ther. 2013;39:87–97 (In Japanese). Asakura S, Inoue S, Sasaki F, Sasaki Y, Kitagawa N, Inoue T, et al. Reliability and validity of the Japanese version of the Liebowitz social anxiety scale. Jpn J Psychiatr Med. 2002;44:1077–84 (In Japanese). Liebowitz, MR. Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141-73. New York: Karger. https://www.karger.com/Article/Abstract/414022#, https://doi.org/10.1159/000414022. Field A. Discovering statistics using IBM SPSS statistics. 5th ed. London: SAGE Publications; 2018.